Legal & General Group’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-39,941
| Closed | -$963K | – | 3611 |
|
|
2023
Q1 | $963K | Buy |
39,941
+11,787
| +42% | +$284K | ﹤0.01% | 2167 |
|
|
2022
Q4 | $298K | Buy |
28,154
+7,143
| +34% | +$75.5K | ﹤0.01% | 2470 |
|
|
2022
Q3 | $95K | Sell |
21,011
-14,335
| -41% | -$64.8K | ﹤0.01% | 2841 |
|
|
2022
Q2 | $141K | Buy |
35,346
+2,983
| +9% | +$11.9K | ﹤0.01% | 2757 |
|
|
2022
Q1 | $237K | Hold |
32,363
| – | – | ﹤0.01% | 2610 |
|
|
2021
Q4 | $182K | Buy |
32,363
+17,178
| +113% | +$96.6K | ﹤0.01% | 2760 |
|
|
2021
Q3 | $97K | Buy |
15,185
+9,394
| +162% | +$60K | ﹤0.01% | 2857 |
|
|
2021
Q2 | $49K | Sell |
5,791
-1,418
| -20% | -$12K | ﹤0.01% | 2960 |
|
|
2021
Q1 | $76K | Buy |
7,209
+100
| +1% | +$1.05K | ﹤0.01% | 2698 |
|
|
2020
Q4 | $120K | Hold |
7,109
| – | – | ﹤0.01% | 2536 |
|
|
2020
Q3 | $91K | Sell |
7,109
-1,306
| -16% | -$16.7K | ﹤0.01% | 2518 |
|
|
2020
Q2 | $119K | Buy |
+8,415
| New | +$119K | ﹤0.01% | 2485 |
|